Stockholders’ Equity (Details) - USD ($)						1 Months Ended							3 Months Ended			9 Months Ended		12 Months Ended
	May 31, 2023	May 09, 2023	Mar. 29, 2023	Nov. 10, 2022	Aug. 11, 2022	Aug. 16, 2023	Jul. 31, 2023	Apr. 30, 2023	Apr. 30, 2022	Apr. 19, 2022	Feb. 23, 2022	Feb. 17, 2022	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Nov. 18, 2022	Aug. 31, 2022	May 24, 2022
Stockholders’ Equity [Line Items]
Common stock, shares authorized											250,000,000		250,000,000			250,000,000		250,000,000
Preferred stock, shares authorized											10,000,000		10,000,000			10,000,000		10,000,000
Preferred stock, par value (in Dollars per share)											$ 0.00001		$ 0.00001			$ 0.00001		$ 0.00001
Shares designated as convertible preferred stock													10,000			10,000		0
Common stock price per share (in Dollars per share)												$ 9	$ 0.5254			$ 0.5254
Preferred Stock, Liquidation Preference, Value (in Dollars)													$ 1,000			$ 1,000
Common stock, shares issued													18,336,597			18,336,597		15,724,957
Common stock, shares outstanding													17,819,198			17,819,198		15,265,228
Common stock, voting rights																one
Aggregate shares												2,222,222				5,709,935
Underwriting discount percentage											8.00%
Net proceeds (in Dollars)											$ 17,100,000
Shares of common stock				5,000,000
Maximum price per (in Dollars per share)				$ 1															$ 2
Repurchased shares																57,670
Aggregate amount (in Dollars)																$ 59,000
Average price per share (in Dollars per share)																$ 1.02
Remaining shares																4,500,000
Shares of common stock											1,600,000
Aggregate shares of common stock							4,972,428		1,180,812
Agent fees and other offering expenses (in Dollars)										$ 6,900,000
Warrants exercise price (in Dollars per share)													$ 1.09			$ 1.09					$ 0.001
Exercise price (in Dollars per share)							$ 1.09			$ 6.65
Agent fee percentage																7.50%
Management fee percentage																1.00%
Out of pocket expenses (in Dollars)																$ 85,000
Purchase of common stock																220,997
Percentage of purchase warrants																6.00%
Exercise price, per share (in Dollars per share)													$ 8.46875			$ 8.46875				$ 2.546
Fair value of contingent warrant liability													646,640			646,640		1,686,640
Preferred investment options													2,486,214			2,486,214
Percentage of common stock shares																6.00%
Exercise price (in Dollars)														$ 459	$ 1,655
Contingent warrants issuable																298,346
Warrants issuable shares																70,849
Contingent warrants exchanged																70,849
Description of contingent warrant liability																The remaining 227,497 August Contingent Warrants were measured as a liability upon the close of the August 2022 Private Placement.
Issuance of warrants to Wainwright as settlement													149,173			149,173
Restricted shares of common stock			3,900,000
Original exercise price (in Dollars)							$ 2.546
Unissued shares of warrant													911,214			911,214
Fees and expenses of legal counsel (in Dollars)																$ 50,000
Non-accountable expenses (in Dollars)																35,000
Equity issuance cost (in Dollars)																2,600,000
Reduction of additional paid in capital (in Dollars)													$ 26,000			$ 26,000
Shares of common stock per value (in Dollars per share)													$ 0.51			$ 0.51
Contingent warrants (in Dollars)																$ 10,000
Common stock reserved for issuance	3,150,000																			2,600,000
Issuance options																1,146,878
Weighted average grant date fair value (in Dollars per share)																$ 1.08
Aggregate fair value of stock options vested (in Dollars)													$ 137,000			$ 616,000
Restricted stock granted		487,500
Description of restricted stock																All of the restricted shares granted vest as follows: 50% in January 2024, 25% in August 2024, and 25% in August 2025.
Outstanding stock options (in Dollars)																$ 394,000
Unvested restricted stock (in Dollars)																	$ 143,000
Common Stock [Member]
Stockholders’ Equity [Line Items]
Common stock, shares issued														18,336,597				15,724,957
Common stock, shares outstanding														17,819,198				15,265,228
Preferred investment options							2,486,214
Exercise price (in Dollars)															$ 2
Issuance of common stock from exercise of preferred investment options													1,575,000
Pre-Funded Warrants [Member]
Stockholders’ Equity [Line Items]
Aggregate shares of common stock					2,333,280					590,406
Purchase price per share (in Dollars per share)										$ 6.774
Warrants exercise price (in Dollars per share)														$ 0.001
2019 Equity Incentive Plan [Member]
Stockholders’ Equity [Line Items]
Shares of common stock													1,400,000			1,400,000
Minimum [Member]
Stockholders’ Equity [Line Items]
Issuance of common stock from exercise of preferred investment options																1,575,000
Weighted-average period term																	1 year 5 months 26 days
Maximum [Member]
Stockholders’ Equity [Line Items]
Issuance of common stock from exercise of preferred investment options																2,486,214
Weighted-average period term																1 year 8 months 1 day
Preferred Investment Options [Member]
Stockholders’ Equity [Line Items]
Aggregate shares of common stock					4,972,428					1,180,812
Purchase price per share (in Dollars per share)					$ 2.715					$ 6.775
Preferred investment options exercise price (in Dollars per share)								$ 8.46875
Exercise price (in Dollars)																$ 3.3938
Market Offering Agreement [Member]
Stockholders’ Equity [Line Items]
Commission fixed rate, percentage			3.00%
Contingent Warrant Liability [Member]
Stockholders’ Equity [Line Items]
Percentage of exercise of PIO																1.00%
Contingent Warrant Liability [Member]
Stockholders’ Equity [Line Items]
Issuance of warrants to Wainwright as settlement													149,173			149,173
Net proceeds of warrant (in Dollars)							$ 2,300,000
Percentage of preferred investment option																7.50%
Fair value of warrant liability (in Dollars)													$ 129,000			$ 129,000
Warrant [Member]
Stockholders’ Equity [Line Items]
Warrants exercise price (in Dollars per share)													$ 1.3625			$ 1.3625
Issuance of warrants to Wainwright as settlement													447,519			447,519		298,346
Inducement Contingent Warrants [Member]
Stockholders’ Equity [Line Items]
Exercise price (in Dollars per share)																$ 1.3625
Warrants issuable shares										298,346
Warrant, Down Round Feature, Decrease in Net Income to Common Shareholder, Amount (in Dollars)																$ 2,300,000
August Contingent Warrants [Member]
Stockholders’ Equity [Line Items]
Fair value of contingent warrant liability													149,173			149,173
Wainwright Inducement Warrants [Member]
Stockholders’ Equity [Line Items]
Other income (expense) (in Dollars)																$ 122,000
April Private Placement Warrants [Member]
Stockholders’ Equity [Line Items]
Fair value of contingent warrant liability													70,849			70,849
Private Placement Warrants [Member]
Stockholders’ Equity [Line Items]
Shares of common stock										590,406
Warrants exercise price (in Dollars per share)													$ 7,899,661			$ 7,899,661
Issuance of contingent warrants													70,849			70,849
Preferred stock, shares issued					1,350,000
Net cash proceeds (in Dollars)					$ 8,700,000
Exercise price (in Dollars)																$ 3.3938
Exchanged preferred investment options																1,289,148
Exercisable shares of common stock													5,121,601			5,121,601
Private Placement Warrants [Member] | Preferred Investment Options [Member]
Stockholders’ Equity [Line Items]
Aggregate shares of common stock																1,180,812
Purchase price per share (in Dollars per share)					$ 2.714
Contingent Warrants [Member]
Stockholders’ Equity [Line Items]
Contingent warrants																70,849
August Private Placement Warrant [Member]
Stockholders’ Equity [Line Items]
Fair value of contingent warrant liability													2,707,211			2,707,211
Series A Preferred Stock [Member]
Stockholders’ Equity [Line Items]
Shares designated as convertible preferred stock													10,000			10,000
Convertible Preferred Stock [Member]
Stockholders’ Equity [Line Items]
Conversion price (in Dollars)																$ 1,000
Common Stock [Member]
Stockholders’ Equity [Line Items]
Percentage of preferred investment option																6.00%
Options [Member]
Stockholders’ Equity [Line Items]
Preferred investment options													2,486,214			2,486,214
Chief Executive Officer [Member]
Stockholders’ Equity [Line Items]
Restricted stock granted		150,000
Forfeited shares of unvested restricted stock						150,000
Chief Financial Officer [Member]
Stockholders’ Equity [Line Items]
Restricted stock granted		75,000
Chief Business Officer [Member]
Stockholders’ Equity [Line Items]
Restricted stock granted		150,000
Non-executive Board [Member]
Stockholders’ Equity [Line Items]
Restricted stock granted	25,440
H.C. Wainwright & Co., LLC [Member]
Stockholders’ Equity [Line Items]
Agent fee percentage								7.50%
Management fee percentage								1.00%
Out of pocket expenses (in Dollars)								$ 85,000
Purchase of common stock								70,849